Clinical Trial 54367

Berlin, NJ 08009


A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

Qualified Participants Must:

• Be 18 - 65 years old
• Be diagnosed with panic disorder
• Have had a minimum of 8 panic attacks in the past month
• Additional criteria apply

Qualified Participants May Receive:

Up to $820 for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.